Italian investment bank Mediobanca $MB.MI is reportedly considering a postponement of its crucial shareholder vote scheduled for Monday regarding its proposed acquisition of Banca Generali $BGN.MI. The board convened on Sunday following concerns raised by several shareholders requesting additional clarity on the terms and rationale of the transaction.

Target Corp. $TGT finds itself at a crucial juncture as the company’s CEO, Brian Cornell, faces intensifying scrutiny. The recent downward revision of sales projections has drawn attention to Target's operational challenges in a turbulent retail environment. Falling consumer expenditures, amplified by tariff burdens and the aftereffects of public boycotts, have forced the retailer to adopt a more cautious outlook.

Novavax Inc. $NVAX shares experienced a sharp rise following the announcement that the US Food and Drug Administration (FDA) granted full approval for its Covid-19 vaccine. This development alleviated investor concerns after previous delays in authorization and public doubts voiced by US Secretary of Health and Human Services, Robert F. Kennedy Jr., regarding the product's effectiveness.

Amid ongoing global economic uncertainty and heightened market volatility, South Korean manufacturer Samsung SDI has opted to adjust the terms for its new share offering. Previously announced at 169,200 KRW per share, the price has now been reduced to 146,200 KRW (approximately US$98.41), marking a 14% decrease. With this move, the company aims to raise 2 trillion KRW (roughly US$1.4 billion), with the final pricing slated for confirmation on May 19. This decision reflects the evolving landscape of global finance, where factors such as tariff policies continue to influence corporate initiatives and investor sentiment.